falegaosimea Outlets mo EUR i Fa'atauga CAS 1451-83-8 2-Bromo-3-Methylpropiophenone 2-Bromo-1- (3-methylphenyl) Propan-1-One/236117-38-7/59774-06-0/1009- 14-9/705-60-2

O la matou kamupani o loʻo faʻamamafaina le pulega, le faʻaofiina o tagata talenia, ma le fausiaina o fale faigaluega, taumafai malosi e faʻaleleia le lelei ma le nofo aitalafu o tagata faigaluega.Na maua manuia e le matou kamupani le IS9001 Certificate ma European CE Certificate of factory Outlets for EUR in Stock CAS 1451-83-8 2-Bromo-3-Methylpropiophenone 2-Bromo-1- (3-methylphenyl) Propan-1-One/236117-38 -7/59774-06-0/1009-14-9/705-60-2, Matou te faʻamalosia oe e faʻaoga e pei ona matou manaʻomia mo ni soa i totonu o la matou pisinisi.Matou te mautinoa o le ae faʻaalia le faia o se kamupani faʻatasi ma i matou e le gata e fua mai ae e maua ai foi tupe mama.Ua matou saunia e tuʻuina atu ia te oe mea e te manaʻomia.
O la matou kamupani o loʻo faʻamamafaina le pulega, le faʻaofiina o tagata talenia, ma le fausiaina o fale faigaluega, taumafai malosi e faʻaleleia le lelei ma le nofo aitalafu o tagata faigaluega.O le matou kamupani na maua manuia le IS9001 Certification ma European CE Certification ofSaina 1451 83 8 ma CAS 1451 83 8, I aso nei o matou oloa faʻatau atu i totonu o le atunuʻu ma fafo faʻafetai mo le lagolago masani ma fou tagata faʻatau.Matou te tuʻuina atu oloa maualuga ma tau faʻatauva, faʻafeiloaʻi le au faʻatau masani ma fou e galulue faʻatasi ma i matou!

1-Bromo-2-methoxy-3-nitro-benzene o loʻo faʻaaogaina e avea ma mea vavalalata o Eltrombopag .
Eltrombopag, atiina ae e GlaxoSmithKline (GSK) i Peretania ma mulimuli ane atiina ae soofaatasi ma Novartis i Suitiselani, o le muamua ma e naʻo le faʻatagaina laiti mole non peptide TPO receptor agonist i le lalolagi.Eltrombopag na faʻamaonia e le US FDA i le 2008 mo le togafitiga o le idiopathic thrombocytopenic purpura (ITP), ma i le 2014 mo togafitiga o le maʻi aplastic anemia (AA).O le vailaʻau muamua foʻi na faʻamaonia e le US FDA mo togafitiga o le AA i le 30 tausaga talu ai nei.
I le december2012, ua faamaonia e le US FDA Eltrombopag mo le togafitiga o thrombocytopenia i tagata mamaʻi ma hepatitis C (CHC), ina ia hepatitis C maʻi ma le le lelei prognosis ona o le maualalo platelet faitau e mafai ona amata ma tausia interferon faavae togafitiga tulaga mo maʻi ate.I le Fepuari3, 2014, GlaxoSmithKline na faʻasalalau e le FDA na tuʻuina atu le agavaa o vailaʻau faʻapitoa mo togafitiga o Eltrombopag mo togafitiga o le hemopenia i tagata mamaʻi e maua i le chemicalbook aplastic anemia (SAA) e leʻi tali atoatoa i le immunotherapy.I le aso 24 o Aokuso, 2015, na faʻamaonia ai e le US FDA Eltrombopag mo togafitiga o le thrombocytopenia i tagata matutua ma tamaiti e taʻi 1 tausaga ma sili atu ma le thrombocytopenia puipuia tumau (ITP) e le lava le tali atu i corticosteroids, immunoglobulins poʻo splenectomy.I le Ianuari 4, 2018, na faʻamaonia ai Eltrombopag e lisiina i Saina mo togafitiga o le thrombocytopenia puipuia muamua (ITP).

O la matou kamupani o loʻo faʻamamafaina le pulega, le faʻaofiina o tagata talenia, ma le fausiaina o fale faigaluega, taumafai malosi e faʻaleleia le lelei ma le nofo aitalafu o tagata faigaluega.Na maua manuia e le matou kamupani le IS9001 Certificate ma European CE Certificate of factory Outlets for EUR in Stock CAS 1451-83-8 2-Bromo-3-Methylpropiophenone 2-Bromo-1- (3-methylphenyl) Propan-1-One/236117-38 -7/59774-06-0/1009-14-9/705-60-2, Matou te faʻamalosia oe e faʻaoga e pei ona matou manaʻomia mo ni soa i totonu o la matou pisinisi.Matou te mautinoa o le ae faʻaalia le faia o se kamupani faʻatasi ma i matou e le gata e fua mai ae e maua ai foi tupe mama.Ua matou saunia e tuʻuina atu ia te oe mea e te manaʻomia.
falegaosimea Outlets moSaina 1451 83 8 ma CAS 1451 83 8, I aso nei o matou oloa faʻatau atu i totonu o le atunuʻu ma fafo faʻafetai mo le lagolago masani ma fou tagata faʻatau.Matou te tuʻuina atu oloa maualuga ma tau faʻatauva, faʻafeiloaʻi le au faʻatau masani ma fou e galulue faʻatasi ma i matou!